International Clinical Expansion for Examen Lab Limited
Advanced Sperm DNA Testing for fertility clinics ready to look beyond standard semen analysis
Examen Global Supports IVF clinics, fertility hospitals, urologists, embryologists, and reproductive medicine leaders with advanced sperm DNA Fragmentation Testing powered by SpermComet® Technology.
Helping clinical terms indentify hidden male factor insights that count, motility, and morphology assessment may not fully reveal.
Our Company
Fast Growing Pharma Company
Mattis tristique tincidunt scelerisque neque felis non sed sed dignissim sit ornare fermentum velit amet mauris eget dui scelerisque augue cum tellus aliquet donec leo, euismod id mattis eu, tortor sit eget commodo egestas tincidunt tortor justo, porta pulvinar at.
Odio vel in nunc aenean dignissim dignissim mattis elementum id sed senectus laoreet blandit faucibus vitae quam aliquam nibh lacus, rhoncus massa placerat urna.
Olivia Michelle
Founder, CEO of evermed
Our Values
Congue ultric in pellentesque sodales egestas faucibus accumsan.
01.
Innovation
Id leo massa lacinia morbi pulvinar venenatis, etiam amet purus in interdum proin nisl morbi eleifend.
02.
Teamwork
Senectus nisl ultricies mi urna, curabitur amet adipiscing eget convallis ultricies lacus eget sed adipiscing eu.
03.
Sustainable
Sed morbi ut ullamcorper sodales et congue laoreet massa sit sit hendrerit morbi gravida malesuada sem.
04.
Integrity
Pharetra adipiscing rutrum et imperdiet sapien, semper blandit vulputate morbi bibendum leo et leo in praesent.
05.
Excellence
Adipiscing quis quis rhoncus etiam lobortis feugiat massa augue aliquam, dictum nulla suspendisse congue tincidunt lectus.
06.
Commitment
Morbi habitasse est vitae mauris sit sit luctus vestibulum lorem tincidunt eu leo nulla pellentesque enim.
Our Products
Committed to Quality
Dictum vel donec viverra habitasse vitae commodo neque libero odio tempus eget laoreet id arcu molestie.
Clinical Development
Quam eu aliquet aliquam tincidunt sit at adipiscing.
Regulatory & Access
Vitae non at sed augue mauris diam feugiat.
Biotech
Ornare volutpat, tellus nisl ut non lorem lacinia.
Functional Service
Venenatis laoreet tortor id sapien mattis quis integer.
Science and evidence
Evidence based Sperm DNA Testing backed by Examen research.
Examen’s scientific foundation is built around SpermComet® technology and published research into sperm DNA damage, including single strand and double strand fragmentation. Clinicians are encouraged to review Examen’s evidence base directly.
DNA level insight
Supports deeper assessment beyond count, motility, and morphology.
Responsible interpretation
Designed to complement clinical judgement, not replace it.
Clinician led pathway
Testing decisions should be made by appropriately qualified professionals.
Clinic value
Why leading fertility clinics should consider Examen.
Deeper male factor insight
Advanced Sperm DNA Testing can help identify hidden sperm DNA damage that may not be visible through standard semen analysis alone.
Stronger clinical conversations
Supports more informed counselling around unexplained infertility, recurrent loss, previous ART failure, lifestyle factors, and urology referral.
Clinic differentiation
Clinics may consider Sperm DNA Testing in selected cases under appropriate clinical guidance and in line with local professional standards.
Commercially practical
Creates a premium diagnostic pathway that can support clinical quality, patient trust, and service differentiation.
International logistics support
Supports practical onboarding models for the UAE, MEA, India, GCC, UK, and other international markets.
No major capital investment
Clinics can access specialist Belfast based testing through structured logistics pathways rather than building complex onsite capability.
Commercial value
Premium testing. Practical economics. Stronger patient pathways.
For clinics, the value of advanced Sperm DNA Testing is not only the test fee. It is the ability to strengthen the male fertility pathway, improve patient counselling, support more targeted decision making, and create a differentiated clinical service.
Indicative regional test pricing
AED 3,250 to AED 4,500
Subject to clinic model, region, logistics, volume, and local regulation.
Clinical pathway
Where Sperm DNA Testing may fit within the fertility pathway.
Clinics may consider Sperm DNA Testing in selected cases under appropriate clinical guidance and in line with local professional standards.
Unexplained infertility
Recurrent pregnancy loss
Previous IVF or ICSI failure
Poor embryo development
Male factor infertility
Varicocele assessment pathway
Lifestyle or oxidative stress risk factors
Older paternal age
Before repeat ART cycles where clinically appropriate
After urology or andrology review where indicated
ABout Examen
Specialist male fertility diagnostics from Belfast, United Kingdom.
Examen Lab Limited is a Belfast based specialist laboratory focused on advanced male fertility diagnostics. Through SpermComet® technology and a strong research heritage, Examen supports clinicians seeking deeper insight into sperm DNA damage and its potential relevance within the fertility pathway.
Meet your onboarding lead
Dr. Deepak Songra BDS
Dr. Deepak Songra BDS is Global Development Manager for Examen Lab Limited across MEA, UAE, India, and international markets. With more than 30 years of clinical healthcare experience, he works with IVF clinics, fertility hospitals, urologists, embryologists, laboratory groups, and healthcare partners to support the international integration of advanced Sperm DNA Testing.
Clinical positioning
Commercial viability
Logistics and sample movement
Patient pathway integration
Regional partnership opportunities
ROI modelling
Mission
To help fertility clinics worldwide access advanced Sperm DNA Testing that supports deeper male fertility insight, stronger clinical decision making, and more complete patient counselling.
Vision
To make DNA level male fertility assessment a recognised and accessible part of modern reproductive medicine pathways across international markets.
Values
Scientific integrity, clinical responsibility, evidence based communication, patient centred care, commercial transparency, international partnership, and regulatory compliance.
Professional guide
The Clinic Leader’s Guide to Integrating Advanced Sperm DNA Testing into the Male Fertility Pathway.
A practical guide for IVF clinics, fertility hospitals, urologists, and reproductive medicine teams considering Sperm DNA Fragmentation Testing as part of a more complete male fertility assessment pathway.
Responsible communication
Built for responsible medical communication.
This website is intended for healthcare professionals, clinic leaders, and institutional partners. It does not provide patient specific medical advice. All testing decisions must be made by appropriately qualified clinicians.
DDA aligned design
WCAG 2.2 AA oriented accessibility
Clinician led interpretation
Regional regulatory review required
Clear medical disclaimers
Evidence based copy controls
FAQ
Questions clinic leaders often ask
It is a laboratory assessment designed to provide insight into sperm DNA damage, complementing standard semen analysis where clinically appropriate.
Semen analysis measures baseline parameters such as count, motility, and morphology. Sperm DNA Testing looks deeper at DNA integrity, which may be relevant in selected clinical pathways.
No. It is designed to complement, not replace, semen analysis, clinical assessment, urology input, embryology review, or clinician judgement.
Clinics may consider testing in selected cases including unexplained infertility, recurrent pregnancy loss, previous ART failure, poor embryo development, or male factor assessment.
Testing is performed through Examen’s specialist Belfast based laboratory pathway.
Yes, subject to local regulatory, logistics, consent, and specimen transport requirements being reviewed and approved.
Not necessarily. EXAMEN Global is designed around practical hub and dry shipper models that can avoid the need for complex onsite specialist testing infrastructure.
Use the booking form below or contact Dr. Deepak Songra directly by email, WhatsApp, or telephone.
Book A Briefing
Coordinate your Clinical Integration Briefing with Dr. Deepak Songra BDS.
Select an optimal slot for a 30 minute clinical, commercial, and logistics review.
Current operational window
08:00 AM to 18:00 PM UK GMT. Available 7 days a week.
Dubai, UAE: GMT plus 4 hours.
Mumbai and Delhi: GMT plus 4.5 hours.
Request a clinic ROI Simulator
